IMVARIA Inc.
PrivateLast Round
Strategic
Jan 7, 2026
Company Overview
IMVARIA Inc. operates in Healthcare & Life Sciences and is based in Berkeley, California. Its latest recorded funding round was a Strategic round in January 2026.
IMVARIA Inc. is a healthcare technology company that develops artificial intelligence-driven digital biomarker solutions for the non-invasive diagnosis and assessment of interstitial lung diseases and idiopathic pulmonary fibrosis.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics, Computer Vision
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IMVARIA Inc. Comparables
Compare IMVARIA Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Revenio Group | 83% | |
| Brainomix | 78% | |
| Optellum | 78% |
For institutional investors. Book with your work email.
IMVARIA Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jan 7, 2026 | ||||
| Grant | Sep 3, 2025 | ||||
| Accelerator | Jun 15, 2021 | ||||
| Accelerator | Jun 10, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
IMVARIA Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UCSF Rosenman Institute | Accelerator |
| MedTech Innovator | Accelerator |
| NIH RADx | Grant |
| Inhealth Ventures | Strategic |
| Cedar Crest Capital | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 3, 2025
Received grant funding from NIH RADx.
- May 18, 2025
Presented AI diagnostic referral service results at ATS 2025.
For institutional investors. Book with your work email.
IMVARIA Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about IMVARIA Inc.'s valuation, stock price, and market status.
Is IMVARIA Inc. a public or private company?
IMVARIA Inc. is a private company.
What is the current stock price of IMVARIA Inc.?
IMVARIA Inc. is a private company, so its shares have no public market price. Caplight tracks IMVARIA Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is IMVARIA Inc. worth (valuation)?
Valuation information for IMVARIA Inc. is not publicly available.
Can I buy IMVARIA Inc. stock?
IMVARIA Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was IMVARIA Inc.'s last funding round?
IMVARIA Inc.'s most recent funding round was Strategic on January 7, 2026.
Who are the main investors in IMVARIA Inc.?
Key investors in IMVARIA Inc. include NIH RADx, Inhealth Ventures.
Will IMVARIA Inc. IPO soon?
No public IPO plans have been announced for IMVARIA Inc..
How can I track IMVARIA Inc. secondary market activity?
Caplight tracks bids, offers, and trades in IMVARIA Inc.'s shares on secondary markets.